有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(2R)-butan-2-yl]-2-[[5-(2-methylfuran-3-yl)-4-(2-methylpropyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C17H26N4O2S |
|
—— | 2-[[5-(2-methylfuran-3-yl)-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]-N-(thiophen-2-ylmethyl)acetamide | —— | C19H22N4O3S2 |
|
—— | 1-(azepan-1-yl)-2-[[5-(2-methylfuran-3-yl)-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]ethanone | —— | C20H28N4O3S |
|
—— | N-[(2R)-butan-2-yl]-2-[[5-(2-methylfuran-3-yl)-4-[(1S)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C21H26N4O2S |
|
—— | 2-[[5-(2-methylfuran-3-yl)-4-[(1S)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]-N-prop-2-enylacetamide | —— | C20H22N4O2S |
|
—— | N-[(2R)-butan-2-yl]-2-[[4-butyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C17H26N4O2S |
|
—— | 1-(azepan-1-yl)-2-[[5-(2-methylfuran-3-yl)-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]ethanone | —— | C20H28N4O3S |
|
—— | 2-[[4-(3-methoxypropyl)-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide | —— | C20H30N4O3S |
|
—— | 2-[[4-(3-methoxypropyl)-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(1R,2S)-2-methylcyclohexyl]acetamide | —— | C20H30N4O3S |
|
—— | (2R)-N-methyl-N-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methyl]-2,3-dihydro-1-benzothiophene-2-carboxamide | —— | C18H16N4O2S |
|
—— | 2-butylsulfanyl-6-[(6S)-6-[(dimethylamino)methyl]-1,4-oxazepan-4-yl]pyrimidin-4-amine | —— | C16H29N5OS |
|
—— | (2S)-N-methyl-N-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methyl]-2,3-dihydro-1-benzothiophene-2-carboxamide | —— | C18H16N4O2S |
|
—— | 2-butylsulfanyl-6-[(6R)-6-[(dimethylamino)methyl]-1,4-oxazepan-4-yl]pyrimidin-4-amine | —— | C16H29N5OS |
|
—— | 3-[4-Amino-3-[(2-methylphenyl)methylsulfanyl]-5-oxo-1,2,4-triazin-6-yl]propanoate | —— | C14H15N4O3S- |
|
—— | 1-(3,4-Difluorophenyl)-3-{[(4-fluorophenyl)methyl]sulfanyl}-1,2-dihydropyrazin-2-one | —— | C17H11F3N2OS |
|
—— | 2-((4-(3-fluoro-4-methylphenyl)-3-oxo-3,4-dihydropyrazin-2-yl)thio)-N-phenethylacetamide | —— | C21H20FN3O2S |
|
—— | N-benzyl-2-[4-(3-chloro-4-fluorophenyl)-3-oxopyrazin-2-yl]sulfanylacetamide | —— | C19H15ClFN3O2S |
|
—— | 1-(2-methylsulfanylpyrimidin-4-yl)-N-[(1R)-1-(4-methyl-1,3-thiazol-2-yl)ethyl]piperidin-4-amine | —— | C16H23N5S2 |
|
—— | (4S)-1-(6-amino-2-butylsulfanylpyrimidin-4-yl)-4-(hydroxymethyl)azepan-4-ol | —— | C15H26N4O2S |
|
—— | 1-(2-methylsulfanylpyrimidin-4-yl)-N-[(1S)-1-(4-methyl-1,3-thiazol-2-yl)ethyl]piperidin-4-amine | —— | C16H23N5S2 |
|
—— | (4R)-1-(6-amino-2-butylsulfanylpyrimidin-4-yl)-4-(hydroxymethyl)azepan-4-ol | —— | C15H26N4O2S |
|
—— | (2R)-N-[2-[(2-chlorophenyl)methylsulfanyl]ethyl]-2-(4-chlorophenyl)sulfanylpropanamide | —— | C18H19Cl2NOS2 |
|
—— | 2-[4-(3-chloro-4-fluorophenyl)-3-oxopyrazin-2-yl]sulfanyl-N-cyclopentylacetamide | —— | C17H17ClFN3O2S |
|
—— | 6-[[4-[(3S)-piperidin-3-yl]triazol-1-yl]methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole | —— | C13H18N6S |
|
—— | 2-butylsulfanyl-6-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]pyrimidin-4-amine | —— | C14H25N5S |
|
—— | 6-[[4-[(3R)-piperidin-3-yl]triazol-1-yl]methyl]-2,3-dihydroimidazo[2,1-b][1,3]thiazole | —— | C13H18N6S |
|
—— | 2-butylsulfanyl-6-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]pyrimidin-4-amine | —— | C14H25N5S |
|
—— | (2S)-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]-2-(2-propan-2-ylimidazol-1-yl)propanamide | —— | C13H21N7OS |
|
—— | (2R)-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]-2-(2-propan-2-ylimidazol-1-yl)propanamide | —— | C13H21N7OS |
|
—— | [(1S)-1-acetamido-2,2,2-trichloroethyl] N,N-bis(2-methylpropyl)carbamodithioate | —— | C13H23Cl3N2OS2 |
|
—— | [(1R)-1-acetamido-2,2,2-trichloroethyl] N,N-bis(2-methylpropyl)carbamodithioate | —— | C13H23Cl3N2OS2 |
|
—— | 2-(4-methylphenyl)sulfanylethyl-[[(2R)-oxolan-2-yl]methyl]azanium | —— | C14H22NOS+ |
|
—— | (2S,6S)-2,6-dimethyl-4-[2-(4-methylphenyl)sulfanylethyl]morpholin-4-ium | —— | C15H24NOS+ |
|
—— | 4-(3-Phenylsulfanylpropyl)morpholin-4-ium | —— | C13H20NOS+ |
|
—— | 1-[2-(2-Phenylsulfanylethoxy)ethyl]piperidin-1-ium | —— | C15H24NOS+ |
|
—— | Furan-2-ylmethyl-[2-(4-methylphenyl)sulfanylethyl]azanium | —— | C14H18NOS+ |
|
—— | (3R)-1-(6-amino-2-butylsulfanylpyrimidin-4-yl)-3-[(dimethylamino)methyl]pyrrolidin-3-ol | —— | C15H27N5OS |
|
—— | (3S)-1-(6-amino-2-butylsulfanylpyrimidin-4-yl)-3-[(dimethylamino)methyl]pyrrolidin-3-ol | —— | C15H27N5OS |
|
—— | N-[(4-chlorophenyl)methyl]-2-({5-[(3-methylphenyl)amino]-1,3,4-thiadiazol-2-yl}sulfanyl)acetamide | —— | C18H17ClN4OS2 |
|
—— | 2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(1R)-1-phenylethyl]acetamide | —— | C19H20N4OS2 |
|
—— | 3-Methyl-7-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanylmethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one | —— | C17H15N5OS3 |
|
—— | N-[(1R)-1-(4-fluorophenyl)ethyl]-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C19H19FN4OS2 |
|
—— | N-[(3-chlorophenyl)methyl]-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C18H17ClN4OS2 |
|
—— | 2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N,N-bis(prop-2-enyl)acetamide | —— | C17H20N4OS2 |
|
—— | ethyl N-[2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetyl]carbamate | —— | C14H16N4O3S2 |
|
—— | N-tert-butyl-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C15H20N4OS2 |
|
—— | N-(1-cyanocyclohexyl)-N-methyl-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C19H23N5OS2 |
|
—— | (2R)-N-benzyl-2-(4-bromophenyl)sulfanylpropanamide | —— | C16H16BrNOS |
|
—— | 1-(2-methylsulfanylpyrimidin-4-yl)-N-[(3R)-thiolan-3-yl]piperidin-4-amine | —— | C14H22N4S2 |
|
—— | (6R)-1,5,6,7-tetrahydroimidazo[2,1-b][1,3]thiazin-4-ium-6-ol | —— | C6H9N2OS+ |
|